Ipilimumab vs Naloxegol Oxalate
Ipilimumab vs Naloxegol Oxalate: Overview
This comparison examines the pharmacological differences between Ipilimumab and Naloxegol Oxalate.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days.
Chemical Properties
Type: Ipilimumab — Antibody; Naloxegol Oxalate — Small molecule.